Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C)
Authors:
Open Access
- 21 January 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-7
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a severe post-COVID condition due to a delayed hyperimmune response to SARS-CoV-2. High-density lipoproteins (HDL) are pivotal players in inflammatory and immune modulation through the remodeling of their subfractions. This study aimed to evaluate serum levels of cholesterol, HDL, and HDL subfractions (HDL-SUB) to define their role in the pathogenesis of MIS-C and their potential use as biomarkers of this condition. We analyzed serum cholesterol, HDL and HDL-SUB (by capillary electrophoresis) in relation to serum values of biomarkers of inflammation and endothelial damage (by microfluidic immunoassays) in 48 patients with MIS-C at hospital admission and in 48 age- and sex-matched healthy controls. Serum cholesterol, as well as HDL, were significantly lower in MIS-C patients than controls. Serum cholesterol was inversely correlated with all biomarkers of inflammation, confirming the impact of cytokines on reverse cholesterol transport, whereas HDL values were inversely correlated with serum biomarkers of endothelial damage, suggesting a role of HDL in endothelial damage in MIS-C patients. Furthermore, we found a remodeling of HDL-SUB with a more pronounced decrease in small HDL that have anti-inflammatory activity. These data confirm the severe impairment of reverse cholesterol transport in MIS-C and indicate serum HDL and HDL-SUB as potential useful diagnostic biomarkers of MIS-C.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2020, code 20209TB4AX)
This publication has 45 references indexed in Scilit:
- Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthoodInternational Journal of Obesity, 2022
- Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patientsScientific Reports, 2022
- Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19Scientific Reports, 2021
- Immunocytometric analysis of COVID patients: A contribution to personalized therapy?Life Sciences, 2020
- COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine stormSignal Transduction and Targeted Therapy, 2020
- Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 InfectionThe Journal of Pediatrics, 2020
- Impaired HDL Function Amplifies Systemic Inflammation in Common Variable ImmunodeficiencyScientific Reports, 2019
- Cholesterol, inflammation and innate immunityNature Reviews Immunology, 2015
- Inflammation alters HDL composition and function: Implications for HDL-raising therapiesPharmacology & Therapeutics, 2013
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999